sulbactam has been researched along with Pneumococcal Infections in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balzanelli, C; Gamba, P; Redaelli de Zinis, LO | 1 |
| Arenoso, H; Casellas, JM; Heguilen, R; Ishida, MT; Israele, V; Marín, M; Sibbald, A; Soutric, J; Stamboulian, D | 1 |
| Borek, AP; Dressel, DC; Hussong, J; Peterson, LR | 1 |
| Arenoso, HJ; Bantar, C; Blanco, M; Fernandez Canigia, L; Jasovich, A; Montoto, M; Nicola, F; Smayevsky, J; Soutric, J | 1 |
1 trial(s) available for sulbactam and Pneumococcal Infections
| Article | Year |
|---|---|
Amoxicillin-sulbactam versus amoxicillin-clavulanic acid for the treatment of non-recurrent-acute otitis media in Argentinean children.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Argentina; Carrier State; Child, Preschool; Drug Administration Schedule; Drug Combinations; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Otitis Media; Pneumococcal Infections; Prospective Studies; Single-Blind Method; Streptococcus pneumoniae; Sulbactam; Treatment Outcome | 2005 |
3 other study(ies) available for sulbactam and Pneumococcal Infections
| Article | Year |
|---|---|
Acute otitis media and facial nerve paralysis in adults.
Topics: Adrenal Cortex Hormones; Adult; Aged; Ampicillin; Cephalosporins; Combined Modality Therapy; Drug Therapy, Combination; Facial Paralysis; Female; Follow-Up Studies; Humans; Male; Mastoid; Middle Aged; Middle Ear Ventilation; Otitis Media; Pneumococcal Infections; Sulbactam; Tomography, X-Ray Computed | 2003 |
Evolving clinical problems with Streptococcus pneumoniae: increasing resistance to antimicrobial agents, and failure of traditional optochin identification in Chicago, Illinois, between 1993 and 1996.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cerebrospinal Fluid; Chicago; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Humans; Male; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Quinine; Respiratory System; Streptococcus pneumoniae; Sulbactam | 1997 |
A pharmacodynamic model to support a 12-hour dosing interval for amoxicillin/sulbactam, a novel oral combination, in the treatment of community-acquired lower respiratory tract infections.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Community-Acquired Infections; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Models, Biological; Moraxella catarrhalis; Neisseriaceae Infections; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Serum Bactericidal Test; Streptococcus pneumoniae; Sulbactam | 2000 |